• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经内分泌调节在肝纤维化中的研究进展

Current Perspectives of Neuroendocrine Regulation in Liver Fibrosis.

机构信息

School of Basic Medical Science, Southwest Medical University, Luzhou 646000, China.

Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.

出版信息

Cells. 2022 Nov 26;11(23):3783. doi: 10.3390/cells11233783.

DOI:10.3390/cells11233783
PMID:36497043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9736734/
Abstract

Liver fibrosis is a complicated process that involves different cell types and pathological factors. The excessive accumulation of extracellular matrix (ECM) and the formation of fibrotic scar disrupt the tissue homeostasis of the liver, eventually leading to cirrhosis and even liver failure. Myofibroblasts derived from hepatic stellate cells (HSCs) contribute to the development of liver fibrosis by producing ECM in the area of injuries. It has been reported that the secretion of the neuroendocrine hormone in chronic liver injury is different from a healthy liver. Activated HSCs and cholangiocytes express specific receptors in response to these neuropeptides released from the neuroendocrine system and other neuroendocrine cells. Neuroendocrine hormones and their receptors form a complicated network that regulates hepatic inflammation, which controls the progression of liver fibrosis. This review summarizes neuroendocrine regulation in liver fibrosis from three aspects. The first part describes the mechanisms of liver fibrosis. The second part presents the neuroendocrine sources and neuroendocrine compartments in the liver. The third section discusses the effects of various neuroendocrine factors, such as substance P (SP), melatonin, as well as α-calcitonin gene-related peptide (α-CGRP), on liver fibrosis and the potential therapeutic interventions for liver fibrosis.

摘要

肝纤维化是一个涉及多种细胞类型和病理因素的复杂过程。细胞外基质(ECM)的过度积累和纤维瘢痕的形成破坏了肝脏的组织稳态,最终导致肝硬化甚至肝功能衰竭。肝星状细胞(HSCs)来源的肌成纤维细胞通过在损伤部位产生 ECM 而促进肝纤维化的发展。据报道,慢性肝损伤时神经内分泌激素的分泌与健康肝脏不同。活化的 HSCs 和胆管细胞对神经内分泌系统和其他神经内分泌细胞释放的这些神经肽表达特定的受体。神经内分泌激素及其受体形成一个复杂的网络,调节肝脏炎症,从而控制肝纤维化的进展。本文从三个方面综述了神经内分泌在肝纤维化中的调节作用。第一部分描述了肝纤维化的机制。第二部分介绍了肝脏中的神经内分泌来源和神经内分泌区室。第三部分讨论了各种神经内分泌因子,如 P 物质(SP)、褪黑素以及α-降钙素基因相关肽(α-CGRP)对肝纤维化的影响,以及肝纤维化的潜在治疗干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7c9/9736734/92e627a277ac/cells-11-03783-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7c9/9736734/8b457149a265/cells-11-03783-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7c9/9736734/d05aa13db523/cells-11-03783-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7c9/9736734/92e627a277ac/cells-11-03783-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7c9/9736734/8b457149a265/cells-11-03783-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7c9/9736734/d05aa13db523/cells-11-03783-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7c9/9736734/92e627a277ac/cells-11-03783-g003.jpg

相似文献

1
Current Perspectives of Neuroendocrine Regulation in Liver Fibrosis.神经内分泌调节在肝纤维化中的研究进展
Cells. 2022 Nov 26;11(23):3783. doi: 10.3390/cells11233783.
2
Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells.肝纤维化:从基础科学到临床进展,聚焦于肝星状细胞的核心作用。
Int J Mol Sci. 2024 Jul 18;25(14):7873. doi: 10.3390/ijms25147873.
3
Wound healing and local neuroendocrine regulation in the injured liver.肝脏损伤中的伤口愈合与局部神经内分泌调节
Expert Rev Mol Med. 2008 Apr 29;10:e11. doi: 10.1017/S146239940800063X.
4
Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.Ⅰ型胶原酶和丙丁酚载药纳米颗粒穿透细胞外基质,靶向肝星状细胞,用于肝纤维化治疗。
Acta Biomater. 2024 Feb;175:262-278. doi: 10.1016/j.actbio.2023.12.027. Epub 2023 Dec 21.
5
Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.胶原酶 I 修饰的共递送胶束增强细胞外基质降解和肝星状细胞靶向治疗肝纤维化。
Acta Biomater. 2022 Oct 15;152:235-254. doi: 10.1016/j.actbio.2022.08.065. Epub 2022 Sep 8.
6
Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis.牛磺酸通过抑制自噬和诱导铁死亡来减轻肝星状细胞的激活。
World J Gastroenterol. 2024 Apr 21;30(15):2143-2154. doi: 10.3748/wjg.v30.i15.2143.
7
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.刺猬-YAP 信号通路调控谷氨酰胺代谢以控制肝星状细胞的激活。
Gastroenterology. 2018 Apr;154(5):1465-1479.e13. doi: 10.1053/j.gastro.2017.12.022. Epub 2018 Jan 3.
8
Liver repair and regeneration after ischemia-reperfusion injury is associated with prolonged fibrosis.肝缺血再灌注损伤后修复和再生与纤维化延长有关。
Am J Physiol Gastrointest Liver Physiol. 2019 Mar 1;316(3):G323-G331. doi: 10.1152/ajpgi.00154.2018. Epub 2018 Dec 13.
9
Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis.肝星状细胞与肝纤维化中周围细胞的串扰。
Int Immunopharmacol. 2021 Oct;99:108051. doi: 10.1016/j.intimp.2021.108051. Epub 2021 Aug 18.
10
Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.肝纤维化:是时候针对肝星状细胞的特异性治疗靶点了。
Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):192-197. doi: 10.1016/j.hbpd.2018.04.003. Epub 2018 Apr 21.

引用本文的文献

1
A network pharmacology approach confirms Biejiaxiaozheng pills combat hepatic fibrosis by modulating macrophage inflammation and hepatic stellate cell activation.一种网络药理学方法证实,鳖甲消症丸通过调节巨噬细胞炎症和肝星状细胞激活来对抗肝纤维化。
Sci Rep. 2025 Jul 9;15(1):24638. doi: 10.1038/s41598-025-09002-1.
2
LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.在小鼠中,裸盖菇素和丁香酚可抑制脂多糖诱导的肝脏炎症。
Pharmaceuticals (Basel). 2025 Mar 23;18(4):451. doi: 10.3390/ph18040451.
3
Multi-Organ Denervation: The Past, Present and Future.

本文引用的文献

1
Cortistatin regulates fibrosis and myofibroblast activation in experimental hepatotoxic- and cholestatic-induced liver injury.皮质抑素调节实验性肝毒性和胆汁淤积性肝损伤中的纤维化和肌成纤维细胞激活。
Br J Pharmacol. 2022 May;179(10):2275-2296. doi: 10.1111/bph.15752. Epub 2022 Feb 10.
2
Depletion of serotonin relieves concanavalin A-induced liver fibrosis in mice by inhibiting inflammation, oxidative stress, and TGF-β1/Smads signaling pathway.五羟色胺耗竭通过抑制炎症、氧化应激和 TGF-β1/Smads 信号通路缓解刀豆蛋白 A 诱导的小鼠肝纤维化。
Toxicol Lett. 2021 Apr 1;340:123-132. doi: 10.1016/j.toxlet.2021.01.010. Epub 2021 Jan 8.
3
多器官去神经支配:过去、现在与未来
J Clin Med. 2025 Apr 16;14(8):2746. doi: 10.3390/jcm14082746.
4
MFAP2 promotes HSCs activation through FBN1/TGF-β/Smad3 pathway.MFAP2 通过 FBN1/TGF-β/Smad3 通路促进造血干细胞的激活。
J Cell Mol Med. 2023 Nov;27(21):3235-3246. doi: 10.1111/jcmm.17884. Epub 2023 Aug 27.
Molecular and cellular mechanisms of liver fibrosis and its regression.
肝纤维化及其逆转的分子和细胞机制。
Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):151-166. doi: 10.1038/s41575-020-00372-7. Epub 2020 Oct 30.
4
Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling.新型缺乏 l-组氨酸脱羧酶/组氨酸信号的小鼠模型可改善胆汁损伤和肝纤维化。
Lab Invest. 2020 Jun;100(6):837-848. doi: 10.1038/s41374-020-0405-8. Epub 2020 Feb 13.
5
Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.Galanin 受体在胆管细胞和肝星状细胞上的协调靶向改善多药耐药蛋白 2 敲除小鼠的肝纤维化。
Am J Pathol. 2020 Mar;190(3):586-601. doi: 10.1016/j.ajpath.2019.10.023. Epub 2020 Jan 14.
6
Expression of neuropeptide Y is increased in an activated human HSC cell line.神经肽 Y 的表达在激活的人 HSC 细胞系中增加。
Sci Rep. 2019 Jul 1;9(1):9500. doi: 10.1038/s41598-019-45932-3.
7
Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes.α-降钙素基因相关肽基因敲除通过差异调节肝星状细胞和胆管细胞的细胞衰老来减轻胆汁淤积性肝损伤。
Lab Invest. 2019 Jun;99(6):764-776. doi: 10.1038/s41374-018-0178-5. Epub 2019 Jan 30.
8
Substance P Promotes Liver Sinusoidal Endothelium-Mediated Hepatic Regeneration by NO/HGF Regulation.P 物质通过 NO/HGF 调节促进肝窦内皮细胞介导的肝再生。
J Interferon Cytokine Res. 2019 Mar;39(3):147-154. doi: 10.1089/jir.2018.0111. Epub 2018 Dec 28.
9
The Secretin/Secretin Receptor Axis Modulates Ductular Reaction and Liver Fibrosis through Changes in Transforming Growth Factor-β1-Mediated Biliary Senescence.胆囊收缩素/胆囊收缩素受体轴通过转化生长因子-β1 介导的胆管衰老改变调节胆小管反应和肝纤维化。
Am J Pathol. 2018 Oct;188(10):2264-2280. doi: 10.1016/j.ajpath.2018.06.015. Epub 2018 Jul 21.
10
Liver fibrosis.肝纤维化
Turk J Gastroenterol. 2018 Jan;29(1):14-21. doi: 10.5152/tjg.2018.17330.